New study hopes to find a simple test for MS diagnosis

NCT ID NCT05056740

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is analyzing inflammatory markers in the blood and spinal fluid of 300 people who are being checked for multiple sclerosis (MS). The goal is to see if certain markers can help doctors tell MS apart from other autoimmune diseases that affect the brain and spinal cord. Researchers will compare these markers with the final diagnosis to find a pattern specific to MS.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this could lead to a simple test using blood and spinal fluid to help doctors diagnose multiple sclerosis more accurately.

What could go wrong

This is an observational study, not a treatment trial. It only looks at existing data, so it cannot prove that any biomarker directly causes or changes the disease.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

central nervous system disorder multiple sclerosis neuromyelitis optica neurosarcoidosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Centre Hospitalier Universitaire de Nice

    RECRUITING

    Nice, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••